Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
If you don't see what is coming you cannot get out of the way...
the great reset
fed rate cut coming today - says USD and metals imo...
its how you have lived your life given the time you had...
WOW - someone tries to kill you and you forgive them - AWESOME!!!
https://www.brighteon.com/b660d14f-a61f-4ce5-b192-831e53b352a8
India's solar farm going to be 6 times the size of Paris France - unreal silver demand
God set us FREE from our bondage yesterday - Thank you Lord!!!
My former employer died today - good riddance - pay up your 1B Oz short!!!
Rot in HELL Assholes for stealing 60K from me
BRICS Oct 22-24 2024 Announcement of BRICS new currency and abandonment of the USD as reserve currency
https://www.brighteon.com/380bdae5-e824-4ffb-88f7-5ae5aaf1dca6
further confirmation - they might even have a pre announcement
just before US election
Mark Cuban vs Donald Trump for President 2024? Could it be?
That would be a very interesting election - hypothetically that is...
Funny Statue video https://www.brighteon.com/397ea6a7-ae3f-4ae8-8b7d-912b5c00f2af
Dow 35K time to bail imo - move to physical silver
https://www.foxnews.com/health/lung-cancer-pill-shows-earth-shattering-results-5-year-study-optimistic-time
Many lung cancer patients now have access to a potentially life-saving medication.
Osimertinib, sold under the brand name Tagrisso, is available to patients with Stage 1B-3A lung cancer who have a certain genetic mutation and have had surgery to remove cancerous tumors.
Among those patients, Tagrisso was shown to reduce the five-year risk of recurrent cancer by up to 73% and the risk of death by up to 51%, according to research published in The New England Journal of Medicine over the summer.
SHOULD YOU BE SCREENED FOR LUNG CANCER BASED ON NEW GUIDELINES FOR HIGH-RISK PATIENTS?
"In the world of oncology, that is earth-shattering," Dr. Faiz Y. Bhora, chief of thoracic surgery and central region chair of surgery at Hackensack Meridian Health in New Jersey, told Fox News Digital.
"In the past, medical oncologists were happy with 5% or 10% — and now we're talking about in excess of 50% improvement in survival."
Dr. Faiz Y. Bhora / Kim Mosko
Dr. Faiz Y. Bhora, chief of thoracic surgery and central region chair of surgery at Hackensack Meridian Health in New Jersey (left), treated Kim Mosko, 67 (right), who is taking Tagrisso after surgery to remove a cancerous tumor. (Hackensack Meridian Health)
Bhora, who has prescribed the medication to several of his lung cancer patients, spoke about the "groundbreaking" results he's seen in his own practice.
"We're truly in the era of personalized medicine," Bhora also told Fox News Digital. "We now have a lot of targeted therapies that work well for patients who have mutations in their tumors."
LUNG CANCER: TYPES, SYMPTOMS AND TREATMENT OPTIONS
For this particular medication, patients who have a genetic mutation called EGFRm — and who have already had surgery — are viable candidates for Tagrisso.
"The pill helps prevent recurrence once the tumor is removed with surgery for those with the genetic marker," he said.
Dr. Faiz Y. Bhora and team
Dr. Faiz Y. Bhora (left) and his team prepare for surgery. "We have perhaps the most outstanding team of thoracic surgeons, who can perform the most complex operations robotically," he told Fox News Digital. (Hackensack Meridian Health)
Patients with stage 4 lung cancer are also eligible for the pill if they have the EGFR mutation, even without having had surgery, the doctor noted.
To determine if a patient has the mutation, a tissue sample is extracted from the tumor and tested. Results are typically obtained within 10 to 14 days.
A blood test is also available, Bhora said, with those results available within five to 21 days.
"We used to think of lung cancer as just a smoker's illness. Now, we know that over 30% of individuals who develop lung cancer have never smoked."
"I would say about 25% of patients with lung cancer end up having an ETFR mutation," the doctor estimated.
Around 238,000 new cases of lung cancer are expected in 2023, according to the American Cancer Society (ACS), along with some 127,000 deaths.
Dr. Faiz Y. Bhora
Dr. Faiz Y. Bhora is pictured during surgery. "Even with some stage 4 patients, we try to treat with systemic therapy first, and if there is residual disease we go in surgically to remove what’s left," he said. (Hackensack Meridian Health)
"We used to think of lung cancer as just a smoker's illness," Bhora said. "Now, we know that over 30% of individuals who develop lung cancer have never smoked, and a lot of them are women."
Looking ahead, he hopes to be able to prescribe the pill soon to patients upfront, before any other procedures or therapies, with the goal of shrinking tumors prior to surgery.
A patient’s story
Kim Mosko, 67, was diagnosed with stage 2A lung cancer in February 2023.
The mother of two had robotic surgery at Hackensack Meridian just a couple of weeks later.
Kim Mosko with husband
Kim Mosko, 67, has been taking Tagrisso for 3½ months. "Overall, my experience has been positive, and I am grateful that this medication is available," she said. (Hackensack Meridian Health)
"The lobectomy was performed by robotic surgery and was an incredible experience," she told Fox News Digital. "I owe all the doctors I see and consulted with a debt I can never repay."
Next, she had four rounds of chemotherapy, which she completed at the end of June 2023.
"I absolutely believe that this medication is going to make sure the lung cancer will not return. I am planning on living for many more years."
When Mosko’s doctors determined in July that she has the genetic mutation, they recommended that she take Tagrisso.
"I needed no persuasion at all," she told Fox News Digital. "I will do whatever is necessary to treat this cancer and lengthen my lifespan."
Kim Mosko with husband
When Mosko’s doctors recommended that she take Tagrisso, "I needed no persuasion at all," she told Fox News Digital. "I will do whatever is necessary to treat this cancer and lengthen my lifespan." (Hackensack Meridian Health)
Mosko has now been taking Tagrisso for 3½ months, with plans to continue taking it daily for three years.
Her insurance covers the cost of the medication.
"Overall, my experience has been positive, and I am grateful that this medication is available," she said.
TWO NEW CANCER PILLS SHOW ‘UNPRECEDENTED’ RESULTS IN BOOSTING SURVIVAL RATES AND PREVENTING RECURRENCE
She has experienced some side effects, such as a skin rash, diarrhea and fatigue, "all of which are manageable," Mosko said.
"I don’t need to have hope," she added. "I absolutely believe that this medication is going to make sure the lung cancer will not return. I am planning on living for many more years."
Where to start
For lung cancer patients interested in Tagrisso, Bhora recommends seeing an experienced team of physicians to get tested for the genetic mutation.
At Hackensack, Bhora said, "we consider every patient a candidate for a cure."
Dr. Faiz Bhora
"This is a very optimistic time for patients who used to have what was universally considered a fatal disease," Bhora said. (Hackensack Meridian Health)
With the advent of personalized therapies, he believes there is hope on the horizon for many lung cancer patients.
CLICK HERE TO SIGN UP FOR OUR HEALTH NEWSLETTER
"This is a very optimistic time for patients who used to have what was universally considered a fatal disease," Bhora said.
"We are now in an era where in a vast majority of cases, we can either turn it into a chronic disease or aim for a complete cure."
"We are now in an era where in a vast majority of cases, we can either turn it into a chronic disease or aim for a complete cure."
Safety information
AstraZeneca, the maker of Tagrisso, indicates on its website that some side effects have been reported.
AstraZeneca North America headquarters
The logo for AstraZeneca is seen outside its North America headquarters in Wilmington, Delaware, March 22, 2021. AstraZeneca is the maker of Tagrisso. (REUTERS/Rachel Wisniewski/File Photo)
The most common of those include low white blood cell counts; low platelet counts; diarrhea; low red blood cell counts (anemia); rash; muscle, bone, or joint pain; mouth sores, fatigue, cough, dry skin; and changes in the fingernails, including redness, tenderness, pain, inflammation, brittleness, separation from the nailbed and shedding of the nail.
Although rare, some potentially serious side effects may affect the lungs, heart, eyes, skin, and blood and bone marrow.
Patients who experience bothersome or long-lasting side effects should consult with their health care provider, AstraZeneca states.
CLICK HERE TO GET THE FOX NEWS APP
They can also report any side effects to the U.S. Food & Drug Administration (FDA) by calling 1-800-FDA-1088.
For more Health articles, visit www.foxnews.com/health.
Melissa Rudy is health editor and a member of the lifestyle team at Fox News Digital.
Yesterday 11/1/2023 Bobby Knight my hero in life died...
But the Texas Rangers also won their 1st world series ever - once they were 1 strike away in 2011
only u can change u:
https://www.brighteon.com/a1122ce0-3847-4455-8015-e7a3dd1bdbdc
What if the USD looses reserve currency and is no longer accepted in 85% of the world?
This could happen at BRICSS+ meeting on August 22nd to 24th imo
Would we drop from 100% down to 20% (Canada, US)? Severe impact on our nuclear power plants imo
Here is where we get our Uranium at-
https://www.eia.gov/energyexplained/nuclear/where-our-uranium-comes-from.php
The United States imports most of the uranium it uses as fuel.
Uranium is the fuel most widely used by nuclear power plants for nuclear fission. Uranium is a common metal found in rocks all over the world. Uranium occurs in combination with small amounts of other elements. There are economically recoverable uranium deposits in the western United States, Australia, Canada, Central Asia, Africa, and South America.
Owners and operators of U.S. nuclear power reactors purchased the equivalent of about 46.74 million pounds of uranium in 2021.
Sources and percentage shares of total U.S. purchases of uranium in 2021 were:
Kazakhstan: 35%
Canada: 15%
Australia: 14%
Russia: 14%
Namibia: 7%
United States: 5%
Five countries combined (W): 10%
Data source: Uranium Marketing Annual Report, Table 3, May 2022
Note: W = data withheld; sum of shares may not equal 100% because of independent rounding.
The chart below shows annual U.S. uranium production and the sources of uranium purchased by U.S. nuclear power plant operators from 1950 through 2021.
Housing shortages- The analysis found four cities are at the epicenter of the crisis, with three located in Texas — San Antonio, Dallas and Houston. Finishing off the list is Orlando, Florida.
https://www.foxweather.com/earth-space/view-perseid-meteor-shower-2023
The best meteor shower in the world, some call it, peaks this week, according to NASA. The Perseid meteor showers are one of the most spectacular, with 50 to 100 "shooting stars" per hour. The max number of meteors will strike the Earth's atmosphere from the evening of August 12 to the morning of August 13.
Water and HE3 on moon - HE3 could solve power needs!!!
https://www.brighteon.com/10b4f9c2-f8ab-4d0f-a34d-a839c2399576
June 2nd - same kind of news
https://www.brighteon.com/a19dfb9c-15ff-40f7-9544-f7e62f5eec42
June 3rd report - 2 minutes - 2 proposals - expansion of members + common currency (to replace USD sadly)
https://www.brighteon.com/9a017ec1-6f01-45cb-a5b4-722c2264d99d
2023 NBA Finals Schedule:
Denver Nuggets (1) vs. Miami Heat (8)
• Game 1: Nuggets 104, Heat 93
• Game 2: Heat vs. Nuggets | Sun., June 4 | 8 p.m. ET (ABC)
• Game 3: Nuggets vs. Heat | Wed., June 7 | 8:30 p.m. ET (ABC)
• Game 4: Nuggets vs. Heat | Fri., June 9 | 8:30 p.m. ET (ABC)
• Game 5: Heat vs. Nuggets | Mon., June 12 | 8:30 p.m. ET (ABC) *
• Game 6: Nuggets vs. Heat | Thurs., June 15 | 8:30 p.m. ET (ABC) *
• Game 7: Heat vs. Nuggets | Sun., June 18 | 8 p.m. ET (ABC) *
Sadly imo... June 2nd 2023 tomorrow... the USD dies...
and loses its status as the worlds reserve currency when...
BRICS+ and a subset of SCO meet and announce they will no longer be using the USD for trade settlement anymore...
rather adopting their own new currency / trade in their own currencies
perhaps they wait until the end of the conference and make the announcement on June 3rd?
Wow 2nd largest ever bank failure in US if i read this right...
https://www.kitco.com/news/2023-03-10/Very-good-week-for-the-gold-market-bulls-what-to-expect-Monday.html
Safe-have demand was featured as Silicon Valley Bank, the 16th largest U.S. bank, collapsed after it experienced a “run” on it by its depositors and investors. While the Federal Deposit Insurance Corporation (FDIC) quickly came in to take over the bank’s assets and accounts, the failure of SVB has badly shaken the general marketplace. It calls into question how aggressive the Federal Reserve can continue to be in tightening its monetary policy to battle problematic price inflation. SVB is reported to be the second-largest bank failure in modern U.S. history.
https://www.riotinto.com/news/releases/2022/Rio-Tinto-starts-tellurium-production-at-Kennecott
Rio Tinto starts tellurium production at Kennecott
11 May 2022
Dave and solar panels, Kennecott operations
Turning slime into solar panels
Our Kennecott copper mine is extracting a rare, valuable metal from waste
READ MORE
SHARE
SALT LAKE CITY--(BUSINESS WIRE)-- Rio Tinto has started producing tellurium at its Kennecott copper operation in Utah, becoming one of only two U.S. producers of the critical mineral used in advanced thin film photovoltaic solar panels.
The tellurium will be refined in North America by 5N Plus, a leading global producer of specialty semiconductors and performance materials, under a commercial agreement between 5N Plus and Rio Tinto. The refined tellurium will primarily be supplied to First Solar, the only American company among the world’s ten largest solar manufacturers, under an existing supply contract between 5N Plus and First Solar. 5N Plus will also use the tellurium to manufacture ultra-high purity semiconductor materials at its facility in St. George, Utah, to serve the security and medical imaging markets.
Approximately 20 tons of tellurium will be produced per year through a new $2.9 million circuit built at the Kennecott refinery. This valuable material is recovered from by-product streams generated during the copper refining process, reducing the amount of waste that needs to be treated and discarded as mine tailings.
Tellurium is listed as a critical mineral by the U.S. Government due to its importance to the economy and energy security.
Rio Tinto Copper Chief Operating Officer Clayton Walker said: “We are proud to deliver a new domestic supply of tellurium to support the manufacturing of solar panels and other critical equipment here in the United States. Approximately 90 percent of the world’s tellurium resource is contained in copper ore and no other metal has more critical mineral by-products than copper. The Kennecott team is constantly looking for ways to extract new critical minerals to meet emerging demand for the clean energy transition.”
5N Plus President and Chief Executive Officer Gervais Jacques said: “As a leading global supplier of specialty semiconductor compounds for applications in renewable energy, security and medical imaging, 5N Plus is proud of this partnership with Rio Tinto, and to further leverage its expertise in the transformation of mining and metallurgical by-products into high purity value-added critical minerals such as tellurium, here in North America.”
First Solar Chief Manufacturing Operations Officer Mike Koralewski said: “Rio Tinto’s decision to invest in tellurium is a win for responsibly-produced, American solar. We’re thrilled that tellurium from Kennecott will play a role in powering our country’s transition to a sustainable energy future.”
Utah Governor Spencer Cox said, “Utah continues to play a key role in domestic production of critical minerals. With operations in our state like Rio Tinto Kennecott, we are able to demonstrate to the world how to responsibly make use of our natural resources to move toward a sustainable future.”
Tellurium is one of ten metals and products recovered from ore extracted at Kennecott, which produces nearly 15 percent of U.S. copper with the country’s lowest carbon footprint.
Notes to editors
Rio Tinto is partnering with the U.S. Department of Energy’s Critical Materials Institute (CMI) to discover further ways to economically recover critical minerals such as tellurium and lithium. The company is also investing in new facilities to extract battery-grade lithium from waste rock at its Boron, California mine site and high-quality scandium oxide from waste streams at its metallurgical complex in Sorel-Tracy, Quebec.
First Solar, which produces cadmium telluride (CadTel) solar panels, is expanding its U.S. manufacturing capacity by 3.3 gigawatts (GW) annually, by building its third American manufacturing facility in Lake Township, Ohio. When fully operational, the new facility will scale the company’s Northwest Ohio footprint to a total annual capacity of 6 GW, which is believed to make it the largest fully vertically integrated solar manufacturing complex outside of China.
riotinto.com
View source version on businesswire.com: https://www.businesswire.com/news/home/20220511005416/en/
Please direct all enquiries to media.enquiries@riotinto.com
Media Relations, UK
Illtud Harri
M +44 7920 503 600
David Outhwaite
M +44 7787 597 493
Media Relations, Americas
Simon Letendre
M +1 514 796 4973
Media Relations, Australia
J onathan Rose
M +61 447 028 913
Matt Chambers
M +61 433 525 739
Jesse Riseborough
M +61 436 653 412
Investor Relations, UK
Menno Sanderse
M: +44 7825 195 178
David Ovington
M +44 7920 010 978
Clare Peever
M +44 7788 967 877
Investor Relations, Australia
A mar Jambaa
M +61 472 865 948
Rio Tinto plc
6 St James’s Square
London SW1Y 4AD
United Kingdom
T +44 20 7781 2000
Registered in England
No. 719885
Rio Tinto Limited
Level 7, 360 Collins Street
Melbourne 3000
Australia
T +61 3 9283 3333
Registered in Australia
ABN 96 004 458 404
Category: Kennecott
Source: Rio Tinto
i take KC cause noone else will!!! Go KC good luck!
wow 11/11 will be out of diesel fuel in 17 days - rumor has it
JP too funny lol - sad that some companies are like that today
https://www.brighteon.com/bb7c322e-5f16-4585-abf4-3f307f5fc183
Volume | |
Day Range: | |
Bid Price | |
Ask Price | |
Last Trade Time: |